Triple Negative Breast Cancer: Updates on Classification and Treatment in 2021

SIMPLE SUMMARY: Triple negative breast cancer (TNBC) represents 15 to 20% of all breast cancers in the United States. The main treatment option remains chemotherapy, despite limited efficacy. New biologic and targeted agents are increasingly emerging for the treatment of TNBC. Given the continuous a...

Descripción completa

Detalles Bibliográficos
Autores principales: Bou Zerdan, Maroun, Ghorayeb, Tala, Saliba, Fares, Allam, Sabine, Bou Zerdan, Morgan, Yaghi, Marita, Bilani, Nadeem, Jaafar, Rola, Nahleh, Zeina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909187/
https://www.ncbi.nlm.nih.gov/pubmed/35267561
http://dx.doi.org/10.3390/cancers14051253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909187/
https://www.ncbi.nlm.nih.gov/pubmed/35267561
http://dx.doi.org/10.3390/cancers14051253

Ejemplares similares